XAAV
Dead / Abandoned — Abandoned — failure to respond (as of 30 Aug 2023)
What this means for you
This application is over — abandoned 14 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79342692
- Mark type
- Stylized text
- Filed
- 28 Feb 2022
- Abandoned
- 14 Aug 2023
Goods and services
- Class 001 — Chemicals: Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes; none of the aforesaid being or including cell growth media
- Class 005 — Pharmaceuticals: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use; none of the aforesaid being or including cell growth media
- Class 042 — Scientific and technological services: Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services; none of the aforesaid services relating to cell growth media
Owner
Prosecution history
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Sept 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Sept 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 31 Aug 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Dec 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 22 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 22 Nov 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 31 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 30 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 30 Aug 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 06 Mar 2023 — REFUSAL PROCESSED BY IB
- 13 Feb 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 13 Feb 2023 — REFUSAL PROCESSED BY MPU
- 12 Jan 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED